twelv
cattl
bodi
wt
rang
kg
treat
use
variou
dose
rout
four
day
e
coli
deriv
alphahybrid
interferon
lowest
parenter
dose
unit
per
kg
bodi
wt
oral
administ
interferon
lead
disturb
wherea
higher
dosag
led
mark
chang
bodi
temperatur
puls
respir
rate
anim
highest
dose
unit
per
kg
bodi
wt
becam
extrem
distress
blood
pictur
show
distinct
chang
low
leukocyt
count
treatment
took
week
recov
suggest
dosag
lead
clinic
symptom
best
suit
prophylact
therapeut
purpos
key
word
alphahybrid
interferon
bodi
weight
bodi
temperatur
puls
rate
respiratori
rate
wbc
dosag
rsumr
douz
bovin
pesant
entr
et
ont
traitr
par
de
dose
et
voi
dadministr
varir
pendant
quatr
jour
avec
un
interfrron
alphahybrid
drrivr
de
e
coli
le
dose
le
plu
bass
unitr
par
kg
du
poid
vif
administrr
par
voie
oral
nont
aucun
troubl
tandi
que
le
dose
plu
causaient
de
modif
important
de
la
temprratur
du
corp
ainsi
du
poul
et
de
mouvement
respiratoir
le
animaux
ayant
regu
le
dose
le
plu
unitr
par
kg
du
poid
vif
manifestai
une
drtress
extff
la
formul
leucocytair
subissait
de
changement
import
avec
de
taux
leucocytair
trr
ba
pendant
le
jour
de
traitement
plusieur
semain
nrcessair
pour
retrouv
une
formul
normal
est
que
le
dose
nengendr
pa
de
symptom
cliniqu
sont
le
mieux
approprir
pour
le
but
prophylactiqu
ou
thrrapeutiqu
interfrron
alphahybrid
poid
vif
temprratur
du
corp
taux
du
poul
taux
de
mouvement
respiratoir
taux
leucocytair
dosag
detect
first
applic
interferon
ifn
ifnrush
start
ifn
almost
consid
panacea
viral
agent
initi
stimul
variou
cell
produc
ifn
cattl
viru
induc
highest
titer
mucou
membran
respiratori
genit
tract
bhvi
highli
passag
avirul
strain
mani
year
success
use
paramun
induc
minim
effect
crowd
diseas
treat
bovin
vagin
find
later
confirm
shown
tsmutant
also
induc
ifn
product
differ
ifn
induct
respiratori
tract
calv
three
differ
describ
later
ifn
activ
intestin
tract
induc
rotaviru
also
demonstr
otto
christian
straub
subsequ
variou
synthet
cell
cultur
bacteria
deriv
alphaifn
develop
first
test
ritro
posit
result
howev
ifn
test
ivo
differ
result
report
distinct
protect
effect
achiev
transmiss
gastroenter
viru
newborn
pig
also
cattl
posit
result
obtain
treat
cattl
prophylact
bhvi
bovin
viru
diarrhoea
viru
diseas
vaccinia
viru
infect
therapeut
reason
rota
corona
viru
infect
effect
cours
footandmouth
diseas
viru
infect
also
describ
object
studi
examin
effect
differ
dose
mode
administr
e
coli
deriv
alphahybrid
ifn
test
previous
tissu
cultur
oral
calv
suffer
digest
tract
disord
alphahybridifn
ahifn
e
coli
deriv
purifi
antibodi
free
slightli
modifi
lymphoblastoid
interferon
specif
activ
x
unit
per
ml
develop
provid
hoechst
ag
frankfurt
twelv
cattl
bodi
weight
rang
kg
parenter
oral
treat
variou
dose
ahlfn
summar
tabl
white
blood
cell
pictur
anim
determin
administr
ahifn
togeth
bodi
temperatur
puls
respir
rate
repeat
immedi
administr
hourli
interv
gener
h
later
white
blood
cell
count
also
determin
interv
indic
tabl
intraven
administr
increas
anim
low
dose
no
tabl
higher
dose
produc
distinct
elev
maximum
reach
hour
c
follow
consecut
treatment
increas
less
mark
one
anim
tabl
reach
hour
differ
observ
iv
im
sc
administr
oral
administ
ahifn
produc
chang
mark
rise
observ
anim
receiv
highest
dose
no
tabl
coincid
rise
temperatur
respons
occur
follow
day
reaction
anim
treat
oral
lowest
dose
oral
treat
anim
fail
exhibit
distinct
rise
other
react
mark
increas
anim
start
exampl
rate
reach
h
start
rate
alphahybrid
interferon
tabl
observ
anim
no
tabl
receiv
highest
dose
summari
increas
seriou
nasal
discharg
h
first
inject
still
present
day
labour
breath
anorexia
h
later
increas
saliv
h
third
treatment
anim
trembl
cough
tabl
absolut
number
neutrophil
n
lymphocyt
l
first
administr
ahifn
day
week
week
last
inject
per
mm
blood
l
l
h
foami
nasal
discharg
h
sign
observ
inject
oral
administr
parenter
inject
unit
ahifnkg
bodi
wt
lead
disturb
hofmann
et
al
use
approxim
dose
treatment
digest
disord
calv
seem
like
therefor
posit
result
attribut
treatment
sinc
could
substanti
efficaci
ahifn
treatment
vitro
vivo
rotaand
coronavirus
howev
higher
dose
certainli
harm
good
short
period
time
judg
clinic
sign
long
period
time
evid
chang
white
blood
pictur
rout
parenter
administr
seem
relev
obvious
true
bodi
weight
resp
age
result
gener
agreement
obtain
gitlespi
cowork
unexpect
ifn
administr
influenc
infect
induc
ifn
activ
true
bhvi
therefor
justif
administ
ifn
prior
exposur
result
encourag
concern
bvdv
infect
ifn
act
immunostimul
could
use
improv
immun
respons
especi
follow
vaccin
inactiv
bvdv
vaccin
